Quantcast

Latest Quark Stories

2009-11-02 07:30:00

FREMONT, Calif., Nov. 2 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel RNA interference (RNAi)-based therapeutics, today announced that James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, will present a case history of QPI-1002, the first systemically administered synthetic siRNA, at the Joint Symposium of the 5th Annual Meeting of Oligonucleotide Therapeutics Society and...

2009-10-26 08:00:00

FREMONT, Calif. Oct. 26 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced issuance of Japanese Patent Number: 4354633, titled, "Hypoxia regulated genes," on August 7, 2009. Granted to Quark from a Japanese National Phase application of International (PCT) Patent Application No. PCT/US98/17296, the patent corresponds to U.S. Patent No.s 6,455,674, 6,555,667 and...

2009-08-03 07:30:00

FREMONT, Calif., Aug. 3 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, will participate in multiple roles at IBC's Oligonucleotide Therapeutics: from Concept to Implementation Conference. The conference will take place August 3-5, 2009 in Boston, MA as part of IBC's Drug Discovery...

2009-05-11 08:00:00

FREMONT, Calif., May 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "PF-04523655 (REDD14NP), an siRNA Compound Targeting RTP801, Penetrates Retinal Cells Producing Target Gene Knockdown and Avoiding TLR3 Activation," at the Association for Research in Vision and...

7e41e0fa5f8162e0fca4dabeae0c62881
2009-02-15 15:30:00

Duke and Brookhaven examine free-flowing 'exploding cigars' Several years after Duke University researchers announced spectacular behavior of a low density ultracold gas cloud, researchers at Brookhaven National Laboratory have observed strikingly similar properties in a very hot and dense plasma "fluid" created to simulate conditions when the universe was about one millionths of a second old. The plasma was formed at a colossal 2 million degrees Kelvin temperatures within Brookhaven's...

2008-12-01 12:01:00

Presentation to Highlight Results of Ocular Neuroprotection Candidate FREMONT, Calif., Dec. 1 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that its Chief Operating Officer, Dr. Rami Skaliter is scheduled to present results on the Company's ocular neuroprotection candidate at the 20th Annual Piper Jaffray Health Care Conference to be held December 2-3, 2008...

502d4f1364ceb90cdadec61294134a171
2008-11-14 10:06:20

Soeren Prell and a team of Iowa State University researchers are part of an international research team testing a theory that led to a share of the 2008 Nobel Prize in Physics for Japanese researchers Makoto Kobayashi and Toshihide Maskawa. Prell, an Iowa State University associate professor of physics and astronomy, is part of the BaBar experiment at the U.S. Department of Energy's SLAC National Accelerator Laboratory in Menlo Park, Calif. Prell returned to Iowa State this summer after a...

2008-10-08 06:00:18

By Dennis Overbye A U.S. and two Japanese physicists won the Nobel Prize in Physics on Tuesday for their work exploring the hidden symmetries between elementary particles that are the deepest constituents of nature. Yoichiro Nambu, of the University of Chicago's Enrico Fermi Institute, will receive half of the 10 million kroner prize, or about $1.4 million, awarded by the Royal Swedish Academy of Sciences. Makoto Kobayashi, of the High Energy Accelerator Research Organization in...

2008-10-08 06:00:18

By Dan Vergano Insights into the peculiarities of the smallest subatomic particles and the existence of the universe have netted one American and two Japanese theorists the 2008 Nobel Prize in physics. The Royal Swedish Academy of Sciences awarded half of the $1.4 million prize Tuesday to Yoichiro Nambu, 87, of the University of Chicago and the remainder to Makoto Kobayashi, 64, of Japan's High Energy Accelerator Research Organization and Toshihide Maskawa, 68, of Kyoto University....

37b126e457ee35e8215781e391c27559
2008-10-07 14:00:00

Two Japanese scientists and a Japanese-born American have been awarded the 2008 Nobel Prize in physics for their work with subatomic particles which provided new insights into the nature of matter. The Royal Swedish Academy of Sciences announced the winners - Yoichiro Nambu, Makoto Kobayashi and Toshihide Maskawa "“ on Tuesday. American Yoichiro Nambu, 87, of the University of Chicago, won half of the prize for the discovery of a mechanism called spontaneous broken symmetry in...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'